United States · FDA National Drug Code directory

Phenazopyridine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82804-995_ac155091-ee07-46da-bb25-ff4cd4074610
Product NDC
82804-995
Form
TABLET
Composition / generic term
Phenazopyridine Hydrochloride
Labeler
Proficient Rx LP
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20231019
Source listing expiry
20261231

Source-listed ingredients

  • PHENAZOPYRIDINE HYDROCHLORIDE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (82804-995-00) · 82804-995-00
  • 6 TABLET in 1 BOTTLE (82804-995-06) · 82804-995-06
  • 10 TABLET in 1 BOTTLE (82804-995-10) · 82804-995-10
  • 12 TABLET in 1 BOTTLE (82804-995-12) · 82804-995-12
  • 20 TABLET in 1 BOTTLE (82804-995-20) · 82804-995-20
  • 24 TABLET in 1 BOTTLE (82804-995-24) · 82804-995-24
  • 500 TABLET in 1 BOTTLE (82804-995-55) · 82804-995-55
  • 90 TABLET in 1 BOTTLE (82804-995-90) · 82804-995-90
  • 96 TABLET in 1 BOTTLE (82804-995-96) · 82804-995-96

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →